Single Oral Dose Comparative Bioavailability Study of Investigational Product in Healthy Human Subjects Under Fasting Conditions.

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The sponsor has developed new curcuminoid formulations with the expectation of enhanced bioavailability compared to existing benchmark products. This study aims to evaluate the comparative bioavailability and characterize the pharmacokinetic profile of the test formulations in comparison to the reference formulations in healthy adult subjects under fasting conditions.
Epistemonikos ID: e779bc299784b41fa771ea493d227d42169f5c84
First added on: Aug 27, 2025